- Home
- OIS vs AQST Comparison
OIS vs AQST Comparison
Compare OIS & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIS
- AQST
- Stock Information
- Founded
- OIS 1995
- AQST 2004
- Country
- OIS United States
- AQST United States
- Employees
- OIS N/A
- AQST N/A
- Industry
- OIS Metal Fabrications
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- OIS Industrials
- AQST Health Care
- Exchange
- OIS Nasdaq
- AQST Nasdaq
- Market Cap
- OIS 375.7M
- AQST 390.4M
- IPO Year
- OIS 2001
- AQST 2018
- Fundamental
- Price
- OIS $6.23
- AQST $6.20
- Analyst Decision
- OIS Buy
- AQST Strong Buy
- Analyst Count
- OIS 2
- AQST 7
- Target Price
- OIS $7.25
- AQST $10.29
- AVG Volume (30 Days)
- OIS 484.7K
- AQST 3.7M
- Earning Date
- OIS 10-29-2025
- AQST 11-03-2025
- Dividend Yield
- OIS N/A
- AQST N/A
- EPS Growth
- OIS N/A
- AQST N/A
- EPS
- OIS 0.11
- AQST N/A
- Revenue
- OIS $664,287,000.00
- AQST $44,132,000.00
- Revenue This Year
- OIS N/A
- AQST N/A
- Revenue Next Year
- OIS $5.23
- AQST $51.50
- P/E Ratio
- OIS $57.49
- AQST N/A
- Revenue Growth
- OIS N/A
- AQST N/A
- 52 Week Low
- OIS $3.08
- AQST $2.12
- 52 Week High
- OIS $6.47
- AQST $6.43
- Technical
- Relative Strength Index (RSI)
- OIS 59.24
- AQST 65.35
- Support Level
- OIS $6.14
- AQST $5.47
- Resistance Level
- OIS $6.47
- AQST $5.93
- Average True Range (ATR)
- OIS 0.23
- AQST 0.36
- MACD
- OIS -0.00
- AQST 0.02
- Stochastic Oscillator
- OIS 63.79
- AQST 72.96
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.